Literature DB >> 23318194

[Mycoplasma-related pneumonia: a rare cause of acute respiratory distress syndrome (ARDS) and of potential antibiotic resistance].

B Sztrymf1, F Jacobs, J Fichet, O Hamzaoui, D Prat, A Avenel, C Richard.   

Abstract

INTRODUCTION: Acute respiratory distress syndrome caused by Mycoplasma pneumoniae infection has rarely been described. OBSERVATION: We report a case of community-acquired pneumonia occurring in a patient with Down's syndrome. Persisting hypoxemia raised the questions of nosocomial pneumonia, of the occurrence of a fibrosing alveolitis or of the resistance of the strain to macrolides. After a long period of very severe respiratory impairment, the evolution was progressively favourable and the patient was discharged from ICU with full respiratory recovery 43 days after admission.
CONCLUSION: Acute respiratory distress syndrome caused by M. pneumoniae infection is rare but must be considered when the appropriate clinical and radiological pattern occurs. The question of the susceptibility of the strain to macrolides has to be raised in some circumstances.
Copyright © 2012 SPLF. Published by Elsevier Masson SAS. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 23318194     DOI: 10.1016/j.rmr.2012.06.012

Source DB:  PubMed          Journal:  Rev Mal Respir        ISSN: 0761-8425            Impact factor:   0.622


  9 in total

Review 1.  Atypical Pneumonia: Updates on Legionella, Chlamydophila, and Mycoplasma Pneumonia.

Authors:  Lokesh Sharma; Ashley Losier; Thomas Tolbert; Charles S Dela Cruz; Chad R Marion
Journal:  Clin Chest Med       Date:  2016-12-24       Impact factor: 2.878

Review 2.  [Clinical implications of the genus Mycoplasma].

Authors:  D Gómez Rufo; E García Sánchez; J E García Sánchez; M García Moro
Journal:  Rev Esp Quimioter       Date:  2021-03-18       Impact factor: 1.553

Review 3.  Emergent Pneumonia in Children.

Authors:  Cecilia Perret; Nicole Le Corre; Jose A Castro-Rodriguez
Journal:  Front Pediatr       Date:  2021-06-17       Impact factor: 3.418

4.  Acute respiratory distress syndrome related to Mycoplasma pneumoniae infection.

Authors:  Nouha Chaabane; Elisabeth Coupez; Matthieu Buscot; Bertrand Souweine
Journal:  Respir Med Case Rep       Date:  2016-12-06

5.  Increased procalcitonin level is a risk factor for prolonged fever in children with Mycoplasma pneumonia.

Authors:  Ji Eun Jeong; Ji Eun Soh; Ji Hee Kwak; Hye Lim Jung; Jae Won Shim; Deok Soo Kim; Moon Soo Park; Jung Yeon Shim
Journal:  Korean J Pediatr       Date:  2018-08-15

6.  Viral and bacterial co-infection in hospitalised children with refractory Mycoplasma pneumoniae pneumonia.

Authors:  Xinxing Zhang; Zhengrong Chen; Wenjing Gu; Wei Ji; Yuqing Wang; Chuangli Hao; Yanyu He; Li Huang; Meijuan Wang; Xuejun Shao; Yongdong Yan
Journal:  Epidemiol Infect       Date:  2018-07-04       Impact factor: 4.434

7.  Increased concentrations of soluble B7-H3 and interleukin 36 in bronchoalveolar lavage fluid of Children with Mycoplasma pneumoniae pneumonia.

Authors:  Zhengrong Chen; Xin Zhao; Xinxing Zhang; Guangbo Zhang; Huiming Sun; Wujun Jiang; Yuqing Wang; Canhong Zhu; Wei Ji; Yongdong Yan
Journal:  BMC Infect Dis       Date:  2016-05-17       Impact factor: 3.090

8.  Ameliorative Effects of Infantile Feire Kechuan Oral Solution on Mycoplasma Pneumoniae Pneumonia in Infant Mouse and Rat Models.

Authors:  Shanshan Guo; Lei Bao; Tiange Qu; Xin Mao; Yingjie Gao; Yingli Xu; Xiaolan Cui
Journal:  Evid Based Complement Alternat Med       Date:  2018-09-17       Impact factor: 2.629

9.  Typical or atypical pneumonia and severe acute respiratory symptoms in PICU.

Authors:  Kam Lun Hon; Agnes S Y Leung; Kam Lau Cheung; Antony C Fu; Winnie Chiu Wing Chu; Margaret Ip; Paul K S Chan
Journal:  Clin Respir J       Date:  2014-06-09       Impact factor: 2.570

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.